As of 2024-12-12, the Relative Valuation of Alexion Pharmaceuticals Inc (ALXN) is 85.66 USD. This relative valuation is based on P/E multiples. With the latest stock price at 182.50 USD, the upside of Alexion Pharmaceuticals Inc based on Relative Valuation is -53.1%.
The range of the Relative Valuation is 63.96 - 111.00 USD.
| Range | Selected | |
| Trailing P/E multiples | 23.5x - 31.2x | 27.3x |
| Forward P/E multiples | 24.6x - 42.8x | 33.6x |
| Fair Price | 63.96 - 111.00 | 85.66 |
| Upside | -65.0% - -39.2% | -53.1% |
| Date | P/E |